French Ophthalmic Lens Manufacturers (2026)

French ophthalmic lens manufacturers sit at the centre of a global optical industry that ran past EUR 28 billion in 2025. The country is home to EssilorLuxottica, the world’s largest optical group, alongside specialists like BBGR (now owned by Nikon Optical), Precilens in Creteil, and a long tail of independent labs serving opticians, hospitals, and OEMs. This guide covers who they are, what the 2025-2026 market looks like, and how French lens makers and finishing labs reach buyers without depending on a single trade fair in Milan or Paris.

The French Ophthalmic Lens Landscape

France is the home market of EssilorLuxottica, the Paris-headquartered French-Italian group that came out of the 2018 merger between Essilor and Luxottica. According to the EssilorLuxottica 2024 results coverage, the group reported EUR 26.5 billion in full-year 2024 revenue with +6% growth at constant exchange rates and adjusted net profit of EUR 3.1 billion. Optical (largely prescription lenses and frames) made up roughly three-quarters of revenue, with Varilux, Stellest, and Transitions as the lead lens franchises. CEOs Francesco Milleri and Paul du Saillant described 2024 as the group’s “fourth consecutive year of top-line growth on track with our targets.”

Underneath that headline group sit several distinct French manufacturers and finishing labs. BBGR, founded in 1846 and acquired by Nikon Optical in 2016, operates from production centres in Sezanne and Provins with 750 employees in France, according to the BBGR company page. The company delivers 12 million lenses per year across France and serves around 6 million eyeglass wearers through 6,000 client opticians. The Nikon Lenswear and BBGR Optical brands both come out of those plants, with the “Guaranteed Made in France” label on every pair.

Precilens, founded in 1981 by Francis Vinzia and now run from Creteil outside Paris, is the French specialist in custom soft and rigid contact lenses, orthokeratology night lenses (the DRL range), and myopia control daytime lenses (AMYOPIC). According to the Precilens company page, the lab created the world’s first progressive soft contact lens (C2) in 1981 and now sells into nearly 20 countries across Europe, the US, Japan, and China. It remains 100% French-owned and manufactures everything in France.

Alongside these names sit Carl Zeiss Vision France, the HOYA Lens France finishing footprint, smaller independents like Novacel, and a long tail of frame manufacturers in the Jura cluster around Morez. According to Lunetiers du Jura, the network counts more than 50 companies, over 1,000 jobs, and produces more than 2.5 million frames per year, half exported. Houses like Morel in Morbier (since 1880), Julbo in Longchaumois, Oxibis Group, Maison Bourgeat, and Ateliers Baudin anchor it. Most are family-owned, ISO certified, and largely invisible to international procurement teams.

The 2025-2026 Market

The picture inside France looks healthier than the European market overall. EssilorLuxottica reported EUR 28.5 billion in full-year 2025 revenue, up +11.2% at constant exchange rates, with Q4 2025 revenue at EUR 7.6 billion and growth of +18.4% in the quarter according to its Q4 2025 press release. Myopia management lenses (Stellest) and AI-enabled smart eyewear were the two strongest revenue contributors going into 2026.

On the device side, Mordor Intelligence data on the France ophthalmic devices market puts the market at USD 2.53 billion in 2025, on track for USD 3.95 billion by 2030 at a 7.81% CAGR. Vision care devices (prescription lenses, contact lenses, IOLs, spectacles) account for 62.49% of the market, while diagnostic and monitoring devices are the fastest-growing segment at 8.17% CAGR. Cataract procedures, which drive intraocular lens demand, captured 38.85% of total ophthalmic device revenue in 2025 and are expected to exceed 850,000 annual cases as the over-65 population reaches 26% of French citizens by 2030.

Three other dynamics matter for French lens makers specifically. First, premium IOLs priced three to five times above monofocal alternatives are pulling average selling prices higher in cataract surgery, and French hospitals are buying through framework tenders that favour suppliers with stable EU manufacturing. Second, EssilorLuxottica’s Labex factory in Essonne, inaugurated in May 2025, concentrated all of the group’s French prescription lens production into a single ultra-automated site with 267 employees producing roughly 3 million prescription lenses per year, according to coverage by Usine Nouvelle. That consolidation replaced sites in Antony, Vaulx-en-Velin, Le Mans, Chalons-en-Champagne, and Toulouse. Third, French opticians are still the gatekeepers for premium lens upgrades, and independents face squeezed margins as retail chains expand share. For French lens makers and finishing labs, this means a more concentrated domestic buyer pool and the need to push harder into export markets where French-made still commands a premium.

Conventional Sales Channels Under Pressure

The classic French playbook for selling lenses, frames, and contact lens technologies has not collapsed. Every component of it is getting more expensive and harder to scale.

Trade fairs: the calendar still drives the year

MIDO in Milan is the global anchor event for optics. According to the official MIDO 2025 attendance figures, the February 2025 edition drew more than 42,000 attendees from 168 countries across 1,200 exhibitors (about 930 international) over three days. European visitors rose +9%, Australia +44%, and the Middle East +9%. Lorraine Berton, MIDO President, summed up the mood: “This edition was all about business, networking, and fresh ideas. There was a real buzz among exhibitors, buyers, opticians, and all industry professionals.”

SILMO Paris in late September is the French home fair. The 2025 edition welcomed 33,358 industry professionals, up 6.5% year on year, with 52% international visitors across more than 900 exhibitors and 75,000 square metres of floor space at Paris Nord Villepinte. OPTI Munich in January, Vision Expo East and Vision Expo West in the US, and Hong Kong Optical Fair in November round out the year. A mid-size French lens maker or frame house running three or four of these typically spends EUR 80,000 to EUR 180,000 per fair on booth, freight, regulatory display materials, samples, staff, and travel. Cost per qualified lead lands in the USD 300 to USD 900+ range and depends on which buyers happen to walk past the booth in a hall of 1,000 exhibitors.

Distributor partnerships and retail chain lock-in

Most independent French lens makers and frame houses sell through authorised distributors and optical chains in priority export markets. Those partners handle local registration, optician relationships, and after-sales. The trade-off is that the distributor or chain owns the buyer relationship. When market conditions shift, manufacturers needing to pivot fast into new geographies often discover that their existing partners do not cover them, and building new partnerships in regulated markets typically takes 12 to 24 months from first conversation to first PO.

Optician trade press and association placements

Magazines like Acuite, L’Opticien Lunetier, and Bien Vu still reach opticians, but readership has shifted to email newsletters and short-form video. Print display ads cost EUR 4,000 to EUR 12,000 per page and produce fewer qualified inquiries than they did three years ago. Association placements through AOF or ECOO help with credibility but rarely move pipeline.

Field sales reps: specialist talent, narrow coverage

Lens selling requires reps who can speak the technical and clinical language of each market. A rep covering Germany needs fluency with MDR classification and DRG reimbursement. A US rep needs working knowledge of FDA clearances and VSP and EyeMed vision plan dynamics. A rep into the Gulf needs familiarity with SFDA registration and ministry tender cycles. Covering all of those simultaneously requires a small team. Cost per qualified lead from field reps typically runs USD 500 to USD 1,200+, and each geography still receives partial coverage.

Cold calling: still effective when done properly

Cold outreach into hospital procurement teams, retail chain category buyers, independent optician chains, and contact lens fitters still works, especially when handled in the buyer’s native language with proper technical vocabulary. The problem is scale. Building an in-house team that can run sharp cold conversations in French, English, German, Italian, Spanish, Arabic, Japanese, and Mandarin is prohibitively expensive for an SME with 30 to 200 employees.

Optometrist association placements

Continuing education events and optometric society meetings still drive product adoption in the US and UK, but they scale poorly across borders. A single regional optometry meeting costs EUR 8,000 to EUR 25,000 plus travel, and reach rarely extends beyond a few hundred practitioners.

How AI-Powered Outbound Fits French Lens Makers

A scalable AI outbound engine is not a replacement for clinical relationships, distributor networks, or MIDO. It is a way of running the cold and warm top-of-funnel work at a scale and price point that an SME cannot match with in-house hires.

Multi-market diversification at speed. When a single distributor underperforms or a key retail chain consolidates, a configured engine can run targeted outreach into the Gulf, Southeast Asia, Latin America, and adjacent EU geographies within days. Trade fairs cannot move that fast. Field reps cannot move that fast.

Continuous pipeline, not fair-based selling. Instead of concentrating activity around MIDO in late January and SILMO in late September, the engine keeps conversations moving with optical chains, independents, contact lens specialists, hospital ophthalmology departments, and OEM partners year-round.

Native-language reach. Outreach in French, English, German, Italian, Spanish, Arabic, Portuguese, Japanese, and Mandarin runs concurrently. Your technical and clinical specialists only enter the conversation once a prospect is genuinely qualified.

Signal-aware targeting. The engine watches signals that matter for lens sales: new optical chain expansion, capital equipment budget cycles, retail group acquisitions, new clinical departments opening, recently granted regulatory approvals, and hires of category managers in vision plans and retail groups.

Compliance-aware personalisation. Each message references the prospect’s relevant frameworks (MDR for the EU, FDA for the US, SFDA for Saudi Arabia, PMDA for Japan, NMPA for China), the product classifications they buy, and the optical sub-segment they run. This is research-grade outreach, not template spam.

Cost per qualified lead lands in the USD 150 to USD 300 range depending on geography and product category, and the marginal cost trends down as the system learns. Trade fairs scale linearly. Field reps scale worse than linearly. AI outbound compounds.

To see what this looks like end to end, the how it works page walks through the engine for regulated B2B manufacturers. For broader French context, the French pharma manufacturers export guide and the French surgical instrument manufacturers guide sit alongside this post.

What the First 90 Days Look Like

Days 1-30: Foundation. Define the buyer profile precisely. Optical chains, independent opticians, hospital ophthalmology departments, contact lens fitters, IOL distributors, or OEM frame partners? Which product categories, retail price points, and geographies match your regulatory portfolio and production capacity? Build targeting and messaging that leads with ISO 13485 certification, specific clinical applications, and the French manufacturing heritage that still commands a premium in regulated markets.

Days 31-60: Launch and learn. Run outreach into two or three target markets. Watch response rates, identify which product categories and buyer types surface the strongest interest, and refine. First positive replies from procurement teams and category buyers typically arrive in this window.

Days 61-90: Scale and optimise. Expand into additional markets and buyer segments. Layer in fresh signals such as retail chain expansion, vision plan negotiations, and ophthalmology department launches. By this point you should be running multiple active conversations in parallel and have early qualified opportunities surfacing.

Frequently Asked Questions

Who are the leading French ophthalmic lens manufacturers?

EssilorLuxottica is the global anchor, with its Labex factory in Essonne now consolidating all French prescription lens production. BBGR in Sezanne and Provins is the French manufacturer behind both BBGR Optical and Nikon Lenswear since 2016. Precilens in Creteil leads the French contact lens specialty (progressive soft, orthokeratology, myopia control). Carl Zeiss Vision France and HOYA Lens France operate finishing labs locally, and the Jura cluster around Morez produces over 2.5 million frames per year.

Where is the French ophthalmic and eyewear industry concentrated?

Frame manufacturing is concentrated in the Jura around Morez and Morbier, with over 50 companies in the Lunetiers du Jura network. Lens manufacturing is in Sezanne and Provins (BBGR), Essonne (EssilorLuxottica Labex), Creteil (Precilens), and Dijon (EssilorLuxottica smart eyewear R&D). Corporate headquarters and finishing labs are largely in Paris and Ile-de-France.

How big is the French ophthalmic devices market?

The French ophthalmic devices market was USD 2.53 billion in 2025 and is expected to reach USD 3.95 billion by 2030 at a 7.81% CAGR, according to Mordor Intelligence. Vision care devices account for 62.49% of revenue, and cataract surgery alone drives 38.85% of total device demand. The over-65 share of the population is expected to reach 26% by 2030, which keeps cataract and IOL volume growing.

What is the difference between prescription lenses, contact lenses, and intraocular lenses?

Prescription (Rx) lenses are spectacle lenses cut and finished to a wearer’s prescription. Contact lenses sit on the eye and include daily disposables, monthly silicone hydrogel, rigid gas permeable, orthokeratology night lenses, and myopia control daytime lenses. Intraocular lenses (IOLs) are surgically implanted into the eye, mainly during cataract surgery, and split into monofocal, toric, extended depth of focus, and multifocal. French manufacturers play in all three categories, with EssilorLuxottica leading in spectacle lenses, Precilens in custom contact lenses, and a smaller IOL footprint relative to German and US groups.

How does MDR affect French ophthalmic lens manufacturers?

The European Medical Device Regulation (MDR) has tightened technical documentation, clinical evidence, and post-market surveillance requirements for every lens and ophthalmic device sold in the EU. French SMEs have had to hire additional regulatory staff, reallocate engineering time away from new product development, and in many cases trim older product references that did not justify recertification cost. The upside is that MDR-cleared products are easier to sell in MDR-recognising third markets.

Does this replace attending MIDO, SILMO, or Vision Expo?

No. The major fairs remain useful for product demonstrations, optician feedback, regulatory conversations, and distributor meetings. AI outbound complements them by identifying and warming target buyers before the event and following up systematically afterward, so the booth investment generates returns 12 months a year instead of three days in Milan.

The Bottom Line

The French ophthalmic lens industry sits inside a EUR 28 billion global group (EssilorLuxottica), a EUR 2.5 billion domestic device market, and a Jura frame cluster that exports half its output worldwide. The pressure points are real: MDR compliance load, retail chain consolidation, vision plan negotiation pressure in the US, and rising costs across every conventional sales channel. The manufacturers who build direct, scalable outbound pipelines into new geographies will be the ones that protect margin and grow through the cycle. The ones who keep waiting for the next MIDO will keep competing with 1,000 other exhibitors for the same buyers.

If you build lenses, frames, contact lens technologies, or ophthalmic devices in France and want to test what a scalable outbound engine looks like in your specific category, start a conversation with us.